Dr James Davies writes: For the last 30 years those of us critical of the overprescribing and harms of psychiatric medications have been on the losing side, in the face of a powerful industry-backed medical model that has crowded out alternative voices and visions. The real importance of Wednesday’s Maudsley Debate is that it symbolised […]
Several newspapers have included coverage of today’s Maudsley Debate and BMJ article which consider whether the long-term use of psychiatric drugs is causing more harm than good. The articles include: http://www.theguardian.com/society/2015/may/12/psychiatric-drugs-more-harm-than-good-expert http://www.telegraph.co.uk/news/nhs/11600868/Throw-away-the-antidepressants-urges-leading-scientist.html http://www.independent.ie/life/health-wellbeing/antidepressants-and-drugs-for-dementia-and-adhd-are-harmful-leading-professor-warns-31218279.html Professor Peter Gøtzsche is also mentioned in the lead article on the front page of The Daily Telegraph: http://www.telegraph.co.uk/news/health/news/11601032/NHS-tests-and-drugs-do-more-harm-than-good.html
The BMJ today publishes an article by CEP member Professor Peter Gøtzsche, in which he claims that the long-term use of psychiatric medication is causing more harm than good. The article is timed to co-incide with a Maudsley Debate which will be held today on the same topic. More than half a million people aged above […]
Following its launch last year and the subsequent criticism of its position by prominent psychiatrists in the The Times and The Lancet Psychiatry, the Council for Evidence-based Psychiatry (CEP) responded by issuing a challenge to its critics to engage in an open, public debate on psychiatric drug harm. Taking up this challenge, the Institute of Psychiatry at Kings College London […]
Dr Paula Caplan, associate of the DuBois Research Institute at Harvard University, has written an article exposing historical ties between Dr Allen Frances, lead editor of DSM-IV, and Janssen Pharmaceuticals, a Johnson & Johnson subsidiary and the makers of Risperdal, a second generation antipsychotic. Caplan cites a 2010 court document written by Dr David J Rothman, a […]
Following its launch last year and the subsequent criticism of its position by prominent psychiatrists in the The Times and The Lancet Psychiatry, CEP responded by issuing a challenge to its critics to engage in an open, public debate on psychiatric drug harm. CEP is therefore pleased to announce that Kings College London has agreed to host a […]
Dr Peter Breggin, prominent critic of biological psychiatry and psychiatric medication, has published a new short video summarising the dangerous negative effects of different classes of psychiatric drugs.
Professor Peter Gøtzsche has won first prize in the 2014 BMA book awards in the Basis of Medicine Category with his most recent book, ‘Deadly Medicines and Organised Crime: How Big Pharma Has Corrupted Healthcare’, published by Radcliffe Publishing. Peter is Director of the Nordic Cochrane Centre and a member of CEP. The BMA reviewer commented as […]
David Nutt and colleagues1 represent a brand of psychiatry that wishes to keep its eyes firmly shut when evidence of harms and lack of effectiveness of favoured biological treatments are found. It is therefore unsurprising they take issue with the Council for Evidence-based Psychiatry for publicising evidence that rarely gets discussed; evidence that would enable people […]
The Lancet Psychiatry today published a letter from members of the Council for Evidence-based Psychiatry. The letter is a response to a previous article in The Lancet Psychiatry entitled “Attacks on antidepressants: signs of deep-seated stigma?” which was contributed by Professor David Nutt, Professor Guy Goodwin and others. CEP’s letter can be seen here (no […]
